Encompass Health Corporation $EHC Shares Sold by Dai ichi Life Insurance Company Ltd

Dai ichi Life Insurance Company Ltd cut its stake in shares of Encompass Health Corporation (NYSE:EHC) by 31.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 51,289 shares of the company’s stock after selling 23,242 shares during the quarter. Dai ichi Life Insurance Company Ltd’s holdings in Encompass Health were worth $4,961,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Northwestern Mutual Wealth Management Co. grew its stake in Encompass Health by 3,059,159.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock worth $402,640,000 after buying an additional 3,793,358 shares during the last quarter. AlphaCore Capital LLC acquired a new position in shares of Encompass Health during the fourth quarter valued at $4,881,000. SG Americas Securities LLC grew its position in shares of Encompass Health by 1,070.9% during the fourth quarter. SG Americas Securities LLC now owns 88,054 shares of the company’s stock worth $9,346,000 after acquiring an additional 80,534 shares during the last quarter. Fort Washington Investment Advisors Inc. OH grew its position in shares of Encompass Health by 28.4% during the fourth quarter. Fort Washington Investment Advisors Inc. OH now owns 267,658 shares of the company’s stock worth $28,409,000 after acquiring an additional 59,202 shares during the last quarter. Finally, Sivik Global Healthcare LLC increased its holdings in shares of Encompass Health by 42.9% in the 4th quarter. Sivik Global Healthcare LLC now owns 50,000 shares of the company’s stock worth $5,307,000 after acquiring an additional 15,000 shares during the period. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, EVP Patrick William Tuer sold 682 shares of the business’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the sale, the executive vice president owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. The trade was a 2.68% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.80% of the company’s stock.

Encompass Health Stock Up 1.4%

Encompass Health stock opened at $112.66 on Friday. Encompass Health Corporation has a 52 week low of $92.77 and a 52 week high of $127.99. The stock has a market cap of $11.18 billion, a price-to-earnings ratio of 18.81, a PEG ratio of 2.46 and a beta of 0.74. The company’s 50-day moving average price is $104.97 and its two-hundred day moving average price is $103.80. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.51 by $0.09. The company had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.57 billion. Encompass Health had a net margin of 10.04% and a return on equity of 18.28%. The business’s revenue for the quarter was up 9.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.37 EPS. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, analysts expect that Encompass Health Corporation will post 5.96 EPS for the current fiscal year.

Encompass Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be given a dividend of $0.21 per share. This is a boost from Encompass Health’s previous quarterly dividend of $0.19. The ex-dividend date is Thursday, October 1st. This represents a $0.84 annualized dividend and a dividend yield of 0.7%. Encompass Health’s payout ratio is 12.69%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on EHC. Leerink Partners set a $152.00 target price on shares of Encompass Health in a research note on Friday, May 22nd. Wall Street Zen upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 2nd. TD Cowen started coverage on Encompass Health in a research report on Thursday, May 28th. They set a “buy” rating and a $125.00 price objective for the company. Weiss Ratings lowered Encompass Health from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, June 26th. Finally, Barclays lowered their target price on Encompass Health from $153.00 to $140.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 5th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, Encompass Health presently has an average rating of “Moderate Buy” and an average target price of $143.86.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.